Online & Text Message Reminders for Breast Cancer Screening
(PReVenT Trial)

Recruiting in Palo Alto (17 mi)

Overseen ByPatricia Balthazar, MD,CIIP

Age: 18+

Sex: Female

Travel: May be covered

Time Reimbursement: Varies

Trial Phase: Academic

Waitlist Available

Sponsor: Emory University

No Placebo Group

Trial Summary

What is the purpose of this trial?This clinical trial evaluates the patient reminders and self-referrals via online patient portals and text messaging (PReVenT) intervention for improving adherence to breast cancer screening. Though no doctor referral is required for mammography, adherence to screening mammograms remains low. Barriers to screening mammography can include things like forgetfulness, low motivation, high cost, or lack of knowledge. Patient reminders and self-scheduling assistance may overcome some of these barriers by increasing patients' awareness, motivating them to schedule their mammogram, and improving access by removing the need for a healthcare provider to order the exam. The PReVenT intervention uses online and text-message based patient-reminders and self-referral assistance to increase adherence to breast cancer screening.

Eligibility Criteria

This trial is for women aged 50-74 with an active online patient portal account, a mobile phone number on record, and at least one primary care visit between 2015 and 2021. They must not have had a mammogram in the last two years or any upcoming scheduled ones, no personal history of breast cancer or mastectomy, no severe cognitive impairment or comorbidities.

Inclusion Criteria

I am a woman aged between 50 and 74.

I have an active account on the patient portal.

Exclusion Criteria

I have had breast cancer or a mastectomy before.

I am not in palliative care or hospitalized.

Participant Groups

The study tests if reminders through online portals and text messages can improve adherence to breast cancer screening. It aims to see if these prompts help patients remember and motivate them to schedule their mammograms without needing a doctor's referral.

2Treatment groups

Experimental Treatment

Active Control

Group I: Arm I (PReVenT intervention)Experimental Treatment4 Interventions

Participants receive usual care as well as a portal message reminder to schedule a SM and a callback link if they need assistance. Participants who have not or do not schedule their SM at the time of the first reminder receive a reminder text-message one week later with a link to receive assistance with scheduling.

Group II: Arm II (enhanced usual care)Active Control4 Interventions

Participants receive usual care as well as portal and text messages one week apart with educational materials about healthy eating.